Targovax ASA operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Targovax ASA with three other
miscellaneous service companies in Europe:
4d Pharma Plc
of UNITED KINGDOM
(2019
sales of £211,000.00 [US$263,750.00 ]
),
Fluicell AB
of SWEDEN
(2.49 million Swedish Kronor [US$265,643.76 ]
), and
Hybrigenics SA
which is
based in FRANCE
(200,000.00 Euros [US$222,718.00 ]
).
Sales Analysis.
Sales increased substantially in 2019:
Targovax ASA reported sales of NOK 2.25 million (US$234.22 thousand)
for the
year ending
December of 2019.
This
represents
an
increase of 8,237.0%
versus 2018, when the company's sales were NOK 27,000.00 .